Browse All

Current Filters

CLEAR FILTER x

TITLE

Automated Audio Analysis of Dysarthria in Huntington’s disease (Audio-HD)

Author:Sierra, Luis   Hildebrand, Karen   Ullman, Clementina   Mwangi, Magdaline   O'Connell, Henry   Frank, Samuel   Laganiere, Simon   

Session Name:S37: Movement Disorders: Phenotyping and Biomarkers  

Topic:Movement Disorders  

Program Number:S37.010  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  Canary Speech, Provo, UT  

Visual hallucinations. More than just a psychiatric problem.

Author:Bhatti, Muhammad   

Session Name:P1: Neuro-ophthalmology/Neuro-otology: Case Reports  

Topic:Neuro-ophthalmology/Neuro-otology  

Program Number:P1.011  

Author Institution:Geisinger Health system, Wilkes-Barre, PA  

Impacting the Culture of Neurologic Care: Piloting a Structural Competency Training into Neurology Core Competencies

Author:Anderson, Kendra   Singh, Sonia Kaur   Nguyen, Thy   

Session Name:P3: Education, Research and Methodology: Resident Education 3  

Topic:Education, Research, and Methodology  

Program Number:P3.006  

Author Institution:University of Texas Health Science Center, Houston, TX  

Diversity, Equity, and Inclusion (DEI) Curriculum for Neurology Residency Program

Author:Andino, Diana   Ruland, Sean   Syed, Anam   Mousa-Ibrahim, Fady   

Session Name:P5: Health Care Disparities: Education, Social Work, Access  

Topic:Health Care Disparities  

Program Number:P5.003  

Author Institution:UT Health Austin, Austin, TX  Loyola University Medical Center, Maywood, IL  Rush University Medical Center, Chicago, IL  Nothwestern University Mcgaw Medical Center, Chicago , IL  

MRI, Efficacy, and Safety of Tolebrutinib in Patients with Highly Active Disease (HAD): 2-Year Data from the Phase 2b Long-term Safety (LTS) Study

Author:Fox, Robert   Oh, Jiwon   Arnold, Douglas   Syed, Sana   Xu, Zhixing   Turner, Timothy   Traboulsee, Anthony   Reich, Daniel   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.017  

Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH  St Michael's Hospital, University of Toronto, Toronto, ON, Canada  NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  University of British Columbia, Vancouver, BC, Canada  National Institute of Neurological Disorders and Stroke, Bethesda, MD